Medical/Pharmaceuticals
The Next Chapter of B7-H3: From Systemic Disease to the Brain
Early Data for T-MAXIMUM's B7-H3 Allogeneic CAR-T in Brain Metastases Presented at WCLC 2026 BEIJING, Sept. 21, 2026 /PRNewswire/ -- As B7-H3 ADCs reshape the second-line treatment landscape for small cell lung cancer at WCLC, a more specific question comes into focus: systemic disease now has n...
2026-09-21 19:50
1163
WuXi XDC Celebrates GMP Release of Singapore Site, Ushering in a New Era of Global Expansion
SINGAPORE, Sept. 21, 2026 /PRNewswire/ --WuXi XDC Cayman Inc. ("WuXi XDC", stock code: 2268.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO) focused on the bioconjugate industry, today held a grand GMP release ceremony for its Singapore manufacturing sit...
2026-09-21 17:50
2525
Neuralli™ MP Goes Global: US Probiotic Medical Food Meets Singapore HSA Notification
Milestone Builds on Hong Kong's Healthcare Professionals Choice Probiotic Award and Full US HSA/FSA Payment Eligibility SINGAPORE, Sept. 21, 2026 /PRNewswire/ -- Bened Life, the leader in psychobiotics, has completed voluntary notification for its flagship product, Neuralli™ MP, withSingapore's ...
2026-09-21 15:10
1339
6 countries across Terumo Asia Pacific officially recognized as Best Workplaces™ Certified by Great Place To Work®
SINGAPORE, Sept. 21, 2026 /PRNewswire/ -- Terumo is proud to announce that 6
countries across Terumo Asia Pacific have officially been recognized as Best
Workplaces™ Certified by Great Place To Work®.
2026-09-21 12:00
753
MALAYSIA HEALTHCARE DEEPENS BANGLADESH PRESENCE AS MEDICAL TOURISM DEMAND GROWS
CHATTOGRAM, Bangladesh, Sept. 21, 2026 /PRNewswire/ -- Malaysia Healthcare Travel Council (MHTC) deepened its engagement in Bangladesh through Malaysia Healthcare Week in Bangladesh, held from 16 to 21 September, bringing Malaysian hospitals and healthcare stakeholders together across Dhaka and C...
2026-09-21 10:41
1884
Telix and ITM Join Forces to Create a Radiopharmaceutical Powerhouse
* Transformational merger reinforces Telix's long-term growth strategy as a vertically integrated radiopharmaceutical company with enhanced capabilities across development, isotope production and global manufacturing, underpinned by commercial excellence and the industry's most extensive therap...
2026-09-21 09:59
1851
Antengene Announces First Patient Dosed in Pivotal Phase III CLINCH-3 Study of ATG-022
SHANGHAI and HONG KONG, Sept. 21, 2026 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for autoimmune di...
2026-09-21 08:30
1385
Specialised Therapeutics Expands Partnership with Incyte to Include Ruxolitinib Cream (Opzelura®) in Australia
SINGAPORE, Sept. 20, 2026 /PRNewswire/ -- Independent biopharmaceutical company Specialised Therapeutics (ST)today announced an expansion of its existing partnership with Incyte Biosciences International, an affiliate of Incyte (NASDAQ: INCY), to commercialise, distribute, and register ruxolitini...
2026-09-21 04:00
2196
JACC: Clinical Electrophysiology Publishes 12-Month Outcomes from Field Medical's First-in-Human Field PULSE Trial: 94.2% Per-Vein PVI Durability with Optimized Waveform
Late-breaking HRX data advance Field Medical's "instantaneous ablation"
workflow and expand the clinical evidence for high-voltage focal PFA with the
FieldForce™ PFA System
ATLANTA and CARLSBAD, Calif., Sept. 20, 2026 /PRNewswire/ -- Field Medical,
Inc.
2026-09-20 22:53
2349
S2S China Announces 2026 Finalists, Ten Standout Teams Set to Pitch Global Investors at Westlake University
SHANGHAI, Sept. 20, 2026 /PRNewswire/ -- The inaugural S2S China Symposium has announced the finalists of its 2026 program. Co-hosted by RA Capital Management and Qiming Venture Partners, S2S China is the China chapter of Science2Startup, an invitation-only symposium connecting top academic resea...
2026-09-20 20:24
2681
Accro Bioscience Announces First Patient Dosed in Phase IIb Study of AC-101 in Moderate-to-Severe Ulcerative Colitis
NEW YORK and SUZHOU, China, Sept. 20, 2026 /PRNewswire/ -- Accro Bioscience Inc. (Accro Bio), a clinical-stage biotechnology company pioneering the development of novel therapeutics for immune mediated diseases, today announced the dosing of their first patient in the Phase IIb clinical trial of ...
2026-09-20 18:00
2868
Ping An Good Doctor Launches " Ping An GlobalCare": AI-Powered Multilingual Services Break Down Healthcare Barriers for Expats in China
HONG KONG, Sept. 20, 2026 /PRNewswire/ -- Ping An Healthcare and Technology Company Limited("Ping An Good Doctor" or the "Company"; Stock Code: 1833.HK) recently unveiled its new product "Ping An GlobalCare" (平安跨境康) at the Shenzhen Sci-Tech Innovation Exhibition. Targeting the pain points expats ...
2026-09-20 15:50
2553
BioShanghai Week 2026 Opens -- Joining Forces to Build a Global Biopharmaceutical Innovation Ecosystem
SHANGHAI, Sept. 20, 2026 /PRNewswire/ -- A news report from Yicai Global:
2026-09-20 13:11
2076
Fosun Health Hosts First International Oncology Treatment Forum in Foshan; International Oncology Alliance Officially Established
FOSHAN, China, Sept. 20, 2026 /PRNewswire/ -- The first International Oncology Treatment Forum, hosted by Fosun Health, was held in Foshan, Guangdong Province, China. Oncology experts from multiple countries and regions participated in the exchanges, discussing the development of international r...
2026-09-20 09:00
2247
HONG KONG RADIOLOGIST ADVOCATES HUMAN-CENTRED AI AT UN HUMAN RIGHTS COUNCIL IN GENEVA
Dr. Kevin Lau Chung-hang welcomes deepening Medical AI: AI for Diagnostic Precision, Doctors for Compassionate Care GENEVA and HONG KONG, Sept. 19, 2026 /PRNewswire/ -- Speaking at the 63rd Session of the United Nations Human Rights Council (HRC63) at the Palais des Nations in Geneva, Dr. Kevin ...
2026-09-19 18:42
2660
NAVER D2SF Invests in AI-Driven Precision Medicine Company ImpriMed
* ImpriMed combines ex vivo functional testing with multimodal AI to support personalized cancer treatment decisions and drug development * The investment is part of ImpriMed's $10 million Series A2 bridge round as the company advances U.S. commercialization and expands into Asia * NAVER D2S...
2026-09-18 23:00
3330
Jiahui Health Highlights China's Growing Role in Global Medical Tourism at WTO Public Forum 2026
GENEVA, Sept. 18, 2026 /PRNewswire/ -- China is seeing growing momentum in inbound medical tourism, driven by expanding access to innovative therapies, visa facilitation and the development of internationally oriented healthcare services, Dr. John K. Hsiang, Chairman of Jiahui Health Executive Co...
2026-09-18 21:00
2067
2026 Tang Prize Award Ceremony Honors Six Laureates
Outstanding Achievements for Global Well-Being and Our Shared Future TAIPEI, Sept. 18, 2026 /PRNewswire/ -- The 2026 Tang Prize Award Ceremony brought together all six laureates in Taipei on September 18, with five receiving their awards in person and Biopharmaceutical Science laureate Dr. Steve...
2026-09-18 19:56
616
Rosti Group highlights cutting-edge medical solutions at Medical Fair Asia 2026
SINGAPORE, Sept. 18, 2026 /PRNewswire/ -- A report from Ringiertrade. The recently concluded Medical Fair Asia 2026, Southeast Asia's Leading International Healthcare Trade Fair for the medical and healthcare sectors, provided opportunities for leading companies to unveil their products and ser...
2026-09-18 09:13
2879
A robust adjusted EBIT margin of 18.8%, driven by solid organic revenue growth of 7.4%
PARIS, Sept. 18, 2026 /PRNewswire/ --
2026-09-18 00:33
2344
Week's Top Stories
Most Reposted
Agoda Releases AI Developer Report 2026: Agentic AI Adoption Outpaces Enterprise Readiness Across Southeast Asia and India
[Picked up by 294 media titles]
2026-09-24 10:30
CGS International Convenes China-ASEAN Business Leaders Summit to Deepen Capital Connectivity Across the Corridor
[Picked up by 281 media titles]
2026-09-23 09:00
Malaysia Calls for Shift from Halal-Certified to Halal-Competitive as ASEAN Targets USD5 Trillion Global Halal Economy
[Picked up by 277 media titles]
2026-09-25 14:45
HLB's Flagship CIO Fund Launched with Strategic Alliance with Lombard Odier
[Picked up by 276 media titles]
2026-09-28 23:04
Responsible Fintech Institute Appoints Four Executive Fellows and Elevates Distinguished Professor Patrick H. M. Loh to Co-Founder
[Picked up by 276 media titles]
2026-09-29 09:00
Most Read
Brightray Signs Prefabricated Module Sales Framework Agreement for Planned 40MW AI Data Center Project in Macao
2026-09-25 20:30
13475
Envision Energy Secures TÜV SÜD Certificate for Wind Farm Control System, Strengthening Long-Term Resilience for Future Energy Systems
2026-09-25 20:11
12207
ULTRALOQ Launches Next-Generation Smart Lock Collection: Refining Home Entry with Natural, Intelligent and Trusted Access Solutions
2026-09-26 02:46
11170
